Evidence map›Paper›PMID 37415741›Full record

ArticleOncology research2023

LAMC2 regulates proliferation, migration, and invasion mediated by the Pl3K/AKT/mTOR pathway in oral.

Fayu Shan, Lanlan Liang, Chong Feng, Hongbao Xu, Zirou Wang, Weili Liu, Lingling Pu, Zhaoli Chen, Gang Chen, Xinxing Wang

Open access · hybridAbstract read
In one paragraph

Article in Oncology research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Long non-coding RNA (lncRNA)Translational cancer research · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Fayu ShanDepartment of Environmental Medicine, Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300070, China.
Lanlan LiangDepartment of Environmental Medicine, Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300070, China.
Chong FengDepartment of Environmental Medicine, Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300070, China.
Hongbao XuDepartment of Environmental Medicine, Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300070, China.
Zirou WangDepartment of Environmental Medicine, Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300070, China.
Weili LiuDepartment of Environmental Medicine, Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300070, China.
Lingling PuDepartment of Environmental Medicine, Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300070, China.
Zhaoli ChenDepartment of Environmental Medicine, Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300070, China.
Gang ChenSchool and Hospital of Stomatology, Tianjin Medical University, Tianjin, 300050, China.
Xinxing WangDepartment of Environmental Medicine, Tianjin Institute of Environmental and Operational Medicine, Tianjin, 300070, China.
Tianjin Academy of Environmental Sciences · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Oral squamous cell carcinoma (OSCC) is a common malignant tumor. Recently, Laminin Gamma 2 (LAMC2) has been shown to be abnormally expressed in OSCC; however, how LAMC2 signaling contributes to the occurrence and development of OSCC and the role of autophagy in OSCC has not been fully explored. This study aimed to analyze the role and mechanism of LAMC2 signaling in OSCC and the involvement of autophagy in OSCC. Methods: To explore the mechanism by which LAMC2 is highly expressed in OSCC, we used small interfering RNA (siRNA) to knock down LAMC2 to further observe the changes in the signaling pathway. Furthermore, we used cell proliferation assays, Transwell invasion assays, and wound-healing assays to observe the changes in OSCC proliferation, invasion, and metastasis. RFP-LC3 was used to detect the level of autophagy intensity. A cell line-derived xenograft (CDX) model was used to detect the effect of LAMC2 on tumor growth Results: This study found that the level of autophagy was correlated with the biological behavior of OSCC. The downregulation of LAMC2 activated autophagy and inhibited OSCC proliferation, invasion, and metastasis via inhibiting the PI3K/AKT/mTOR pathway. Moreover, autophagy has a dual effect on OSCC, and the synergistic downregulation of LAMC2 and autophagy can inhibit OSCC metastasis, invasion, and proliferation via the PI3K/AKT/mTOR pathway. Conclusions: LAMC2 interacts with autophagy to regulate OSCC metastasis, invasion, and proliferation via the PI3K/AKT/mTOR pathway. LAMC2 down-regulation can synergistically modulate autophagy to inhibit OSCC migration, invasion, and proliferation.

Indexed as

Carcinoma, Squamous CellHead and Neck NeoplasmsMouth NeoplasmsCell Line, TumorCell MovementCell ProliferationHumansLamininPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRNA, Small InterferingSquamous Cell Carcinoma of Head and NeckTOR Serine-Threonine KinasesLAMC2 protein, humanLamininPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktRNA, Small InterferingTOR Serine-Threonine Kinases3-MethyladenineAutophagyLAMC2OSCCPI3K/AKT/mTOR pathwayRapamycin

Identifiers

PMID37415741
PMCPMC10319602
OpenAlexW4381955811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.